A common SCN5A polymorphism modulates the biophysical effects of an SCN5A mutation

Journal of Clinical Investigation

Volumn 111, Issue 3, 2003, Pages 341-346

  Viswanathan, Prakash C ^a   Benson, D Woodrow ^b   Balser, Jeffrey R ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SODIUM CHANNEL; SODIUM ION;

ARTICLE; ATRIOVENTRICULAR BLOCK; CHANNEL GATING; CLINICAL ARTICLE; FEMALE; GENE; GENETIC POLYMORPHISM; HUMAN; MALE; PEDIGREE; PRIORITY JOURNAL; QRS COMPLEX; QT INTERVAL; SCN5A GENE; SITE DIRECTED MUTAGENESIS; SODIUM CURRENT;

ALLELES; BASE SEQUENCE; DNA, COMPLEMENTARY; ELECTROPHYSIOLOGY; FAMILY HEALTH; FEMALE; GENOTYPE; HUMANS; INFANT; MALE; MEMBRANE POTENTIALS; MOLECULAR SEQUENCE DATA; MUTATION; PEDIGREE; PHENOTYPE; POLYMORPHISM, GENETIC; SODIUM CHANNELS;

EID: 0037314358     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200316879     Document Type: Article

References (28)

1. Wang, Q., et al. 1995. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell. 80:805-811.
2. Chen, Q., et al. 1998 Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature. 392:293-296.
3. Tan, H.L., et al. 2001. A sodium-channel mutation causes isolated cardiac conduction disease. Nature. 409:1043-1047.
4. Dumaine, R., et al. 1999. Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent. Circ. Res. 85:803-809.
5. Veldkamp, M.W., et al. 2000. Two distinct congenital arrhythmias evoked by a multidysfunctional Na(+) channel. Circ. Res. 86:E91-E97.
6. Wang, D.W., Makita, N., Kitabatake, A., Balser, J.R., and George, A.L., Jr. 2000. Enhanced Na(+) channel intermediate inactivation in Brugada syndrome. Circ. Res. 87:E37-E43.
7. Antzelevitch, C., Yan, G.X., and Shimizu, W. 1999. Transmural dispersion of repolarization and arrhythmogenicity: the Brugada syndrome versus the long QT syndrome. J. Electrocardiol. 32(Suppl):158-165.
8. Alings, M., and Wilde, A. 1999. "Brugada" syndrome: clinical data and suggested pathophysiological mechanism. Circulation 99:666-673.
9. Wang, D.W., Viswanathan, P.C., Balser, J.R., George, A.L., Jr., and Benson, D.W. 2002. Clinical, genetic, and biophysical characterization of SCN5A mutations associated with atrioventricular conduction block. Circulation. 105:341-346.
10. Weiss, R., et al. 2002. Clinical and molecular heterogeneity in the Brugada syndrome: a novel gene locus on chromosome 3. Circulation. 105:707-713.
11. Hull, J., and Thomson, A.H. 1998. Contribution of genetic factors other than CFTR to disease severity in cystic fibrosis. Thorax. 53:1018-1021.
12. Roses, A.D. 1998. Apolipoprotein E and Alzheimer's disease. The tip of the susceptibility iceberg. Ann. NY Acad. Sci. 855:738-743.
13. Saunders, A.M., et al. 2000. The role of apolipoprotein E in Alzheimer's disease: pharmacogenomic target selection. Biochim. Biophys. Acta. 1502:85-94.
14. Wilkins, M.R., Roses, A.D., and Clifford, C.P. 2000. Pharmacogenetics and the treatment of cardiovascular disease. Heart. 84:353-354.
15. Splawski, I., et al. 2002. Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia. Science. 297:1333-1336.
16. Yang, P., et al. 2002. Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes. Circulation. 105:1943-1948.
17. + channel mutations in the congenital long QT syndrome. Proc. Natl. Acad. Sci. USA. 93:13200-13205.
18. Bezzina, C.R., et al. 1999. A single Na(+) channel mutation causing both long-QT and Brugada syndromes. Circ. Res. 85:1206-1213.
19. Buyon, J.P. 1998. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J. Am. Coll. Cardiol. 31:1658-1666.
20. Rivolta, I., et al. 2001. Inherited Brugada and long QT-3 syndrome mutations of a single residue of the cardiac sodium channel confer distinct channel and clinical phenotypes. J. Biol. Chem. 276:30623-30630.
21. Viswanathan, P.C., et al. 2001. Gating-dependent mechanisms for flecainide action in SCN5A-linked arrhythmia syndromes. Circulation. 104:1200-1205.
22. Olson, T.M., and Keating, M.T. 1996. Mapping a cardiomyopathy locus to chromosome 3p22-p25. J. Clin. Invest. 97:528-532.
23. Schram, G., Pourrier, M., Melnyk, P., and Nattel, S. 2002. Differential distribution of cardiac ion channel expression as a basis for regional specialization in electrical function. Circ. Res. 90:939-950.
24. Priori, S.G., Napolitano, C., and Schwartz, P.J. 1999. Low penetrance in the long-QT syndrome: clinical impact. Circulation. 99:529-533.
25. Daley, G.Q., and Cargill, M. 2001. The heart SNPs a beat: polymorphisms in candidate genes for cardiovascular disease. Trends Cardiovasc. Med. 11:60-66.
26. Roses, A.D. 2000. Genetic susceptibility to cardiovascular diseases. Am. Heart J. 140:S45-S47.
27. Roses, A.D. 2000. Pharmacogenetics and the practice of medicine. Nature. 405:857-865.
28. Sesti, F., et al. 2000. A common polymorphism associated with antibiotic-induced cardiac arrhythmia. Proc. Natl. Acad. Sci. USA. 97:10613-10618.